Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2039-2025

Brand Name: VITROS; Product Name: VITROS XT 7600 Integrated System; Recall

Brand Name: VITROS; Product Name: VITROS XT 7600 Integrated System; Model/Catalog Number: (1) 6844461, (2) 6272222; Software Version: version 3.2 to version 3.8.3 (all available software versions); Product Description: In vitro diagnostic chemistry analyzer.

FDA recall Class II

Ongoing

FDA lists this Class II recall for Brand Name: VITROS; Product Name: VITROS XT 7600 Integrated System;. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2039-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
May 9, 2025
FDA report date
Jul 9, 2025
Quantity in commerce
1958 units (1019 US, 939 OUS)
Distribution
See key details
FDA cause
Software design

What is being recalled?

Brand Name: VITROS; Product Name: VITROS XT 7600 Integrated System; Model/Catalog Number: (1) 6844461, (2) 6272222; Software Version: version 3.2 to version 3.8.3 (all available software versions); Product Description: In vitro diagnostic chemistry analyzer.

Affected model & UDI checker

Search the exact identifiers published for Z-2039-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
6844461Brand Name: VITROS; Product Name: VITROS XT 7600 Integrated System;Check source notice10758750012343
6272222Brand Name: VITROS; Product Name: VITROS XT 7600 Integrated System;Check source notice10758750012343
FDA code information

VITROS XT 7600 Integrated System; Product Code: 6844461; UDI: 10758750012343; VITROS XT 7600 System - Certified; Product Code: 6272222; UDI: 10758750012343; Range of installed serial numbers:76000109-76002327; Total systems currently installed in the US: 1,019 Total systems currently installed outside the US: 939 Total systems installed worldwide (Product Quantity Distributed): 1,958 Note1: The catalogue number 6844461 is used to denote the VITROS XT 7600 Integrated System. Catalogue number 6272222 is used to denote VITROS XT 7600 System Certified. A VITROS XT 7600 Integrated System maintains its original serial number through the certification process. Therefore, the manufacturing and distribution information for the two catalogue numbers will be combined. Note2: When manufactured, the system s serial numbers are sequential, but not all analyzers are released for distribution and therefore not installed. The range of serial numbers provided includes the identified minimum and maximum in serial numbers associated with all currently installed systems. Therefore, the amount of each system manufactured may not equal the amount of each system installed. Additionally, not all serial numbers listed are associated with an active installed analyzer in use today.

View the original FDA recall notice

Why was this product recalled?

a software anomaly allows test results to be reported using Micro Tip and Micro Slide diluent packs that the system treats as expired even when the Use Expired Reagents setting is not enabled if a shelf expiration date is omitted during manual loading. The issue was identified by a customer complaint, in which a CREA Urine test was processed with an RE (Reagent Expired) code, even though the diluent pack was not expired and the use-expired-reagents setting was disabled. This can result in erroneous test results and/or delaying test results.

What actions did ORTHO-CLINICAL DIAGNOSTICS, INC. take?

On May 22, 2025, "URGENT PRODUCT CORRECTION NOTIFICATION" letters were sent to customers. REQUIRED ACTIONS - To prevent this issue from occurring, the shelf expiration date must be entered when manually loading VITROS Diluent Packs on VITROS 4600/5600/XT 7600 Systems. - View the Reagent Management Supply 3 screen to check for any onboard VITROS Diluent Packs marked as expired. o For all VITROS Diluent Packs marked as expired, navigate to View By Reagent View Dil/ANC and confirm the shelf expiration date matches the shelf expiration date on the product labeling. o If the shelf expiration dates do not match, discard the VITROS Diluent Pack and load a new VITROS Diluent Pack. QuidelOrtho will credit your discarded inventory. (Credit will only be issued for within-expiry products.) - Complete and return the enclosed Confirmation of Receipt form no later than May 30, 2025. Upon receipt of your completed Confirmation of Receipt form, QuidelOrtho will credit or replace your discarded inventory. - Save this notification with your User Documentation or post this notification by each VITROS 4600/5600/XT 7600 System in your laboratory until the issue has been resolved. - Please forward this notification if the affected product was distributed outside of your facility. - If your laboratory has experienced the issue with this product and you have not already done so, please report the occurrence to your local Global Services Organization. Resolution QuidelOrtho has determined root cause, and this issue will be resolved in an upcoming software update. If you have further questions, please contact our Global Services Organization at 1-800-421-3311.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology